|
|
|
Corporate Profile: Pathway Therapeutics
| Summary: |
Pathway Therapeutics is focused on the discovery, research, and development of inhibitors of PI3-kinase (PI3K) and mTOR for the treatment of patients with cancer and inflammatory diseases.
|
| Address (HQ): |
409 Illinois Street
San Francisco, CA 94158 |
| Phone
#'s (HQ): |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s (HQ): |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| email: |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications mentioning company on PubMed: publications
link. |
|
|
|
